Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Stem Cells May Repair Injured Heart Muscle

By Biotechdaily staff writers
Posted on 20 May 2002
An animal study suggests that transplanting embryonic stem cells can help repair injured heart muscle and improve cardiac function following heart attacks and congestive heart failure (CHF). More...
The study was conducted by researchers at Beth Israel Deaconess Medical Center (BIDMC, Boston, MA, USA).

CHF is caused by the destruction of cardiomyocytes during a heart attack, resulting in ventricular dysfunction. The study was designed to determine whether implanted embryonic stem cells could survive in injured heart muscle and improve function. One of the advantages in using embryonic stem cells over other cells is to reduce immunoreactivity. The researchers surgically induced a heart attack in two groups of rats, one treated with a culture of embryonic stem mouse cells and one with a sham culture. Injections of stem cells were made at three separate sites in the heart, one on the place the attack took place and two in the heart muscle bordering the area.

Six weeks later, the researchers found that heart attack damage was reduced in the animals implanted with the stem cells. This group also showed significant improvement in left ventricular function. Animals in the control group did not show any improvement. Calculations revealed that the number of marked cells had successfully replicated, with 7.3% growth in the number of enzymatically isolated single cardiomyocytes. The cells were also rod-shaped with clear striations that mimicked heart muscle cells.

"These data strongly suggest that cardiogenesis, or growth of new cardiomyocytes, occurred in the damaged heart muscle following embryonic stem cell transplantation,” said Dr. Yong Fu Xiao, department of cardiology at BIDMC.




Related Links:
Beth Israel Medical Center

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
Automated Clinical Chemistry Analyzer
Envoy 500+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.